Mid American Wealth Advisory Group, Inc. Passage Bio, Inc. Transaction History
Mid American Wealth Advisory Group, Inc.
- $210 Billion
- Q2 2025
A detailed history of Mid American Wealth Advisory Group, Inc. transactions in Passage Bio, Inc. stock. As of the latest transaction made, Mid American Wealth Advisory Group, Inc. holds 32 shares of PASG stock, worth $259. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32Holding current value
$259% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PASG
# of Institutions
43Shares Held
35.3MCall Options Held
40.5KPut Options Held
0-
Lynx1 Capital Management LP San Juan, PR9.26MShares$75.1 Million1.1% of portfolio
-
Vestal Point Capital, LP New York, NY6.1MShares$49.5 Million0.13% of portfolio
-
Orbimed Advisors LLC San Diego, CA6.06MShares$49.1 Million0.09% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$20.3 Million2.97% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.46MShares$19.9 Million0.01% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $442M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...